%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
Vania Giacomet, Michela Masetti, Pilar Nannini, Federica Forlanini, Mario Clerici, Gian Vincenzo Zuccotti, Daria Trabattoni
Humoral and cell-mediated immune responses after a booster dose of HBV vaccine in HIV-infected children, adolescents and young adults
www.plosone.org
www.plosone.org
endstream
endobj
3 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 9 0 R/Annots 10 0 R/Contents 11 0 R/TrimBox[0 0 612 792]>>
endobj
10 0 obj
[12 0 R 13 0 R 14 0 R 15 0 R 16 0 R 17 0 R 18 0 R 19 0 R 20 0 R 21 0 R 22 0 R 23 0 R 24 0 R 25 0 R 26 0 R 27 0 R 28 0 R 29 0 R]
endobj
12 0 obj
<>/Border[0 0 0]/Dest(Rpone.0192638.ref001)>>
endobj
13 0 obj
<>/Border[0 0 0]/Dest(Rpone.0192638.ref002)>>
endobj
14 0 obj
<>/Border[0 0 0]/Dest(Rpone.0192638.ref003)>>
endobj
15 0 obj
<>/Border[0 0 0]/Dest(Rpone.0192638.ref004)>>
endobj
16 0 obj
<>/Border[0 0 0]/Dest(Rpone.0192638.ref007)>>
endobj
17 0 obj
<>/Border[0 0 0]/Dest(Rpone.0192638.ref008)>>
endobj
18 0 obj
<>/Border[0 0 0]/Dest(Rpone.0192638.ref009)>>
endobj
19 0 obj
<>/Border[0 0 0]/Dest(Rpone.0192638.ref010)>>
endobj
20 0 obj
<>/Border[0 0 0]/Dest(Rpone.0192638.ref011)>>
endobj
21 0 obj
<>/Border[0 0 0]/Dest(Rpone.0192638.ref012)>>
endobj
22 0 obj
<>/Border[0 0 0]/Dest(Rpone.0192638.ref013)>>
endobj
23 0 obj
<>/Border[0 0 0]/Dest(Rpone.0192638.ref014)>>
endobj
24 0 obj
<>/Border[0 0 0]/Dest(Rpone.0192638.ref015)>>
endobj
25 0 obj
<>/Border[0 0 0]/Dest(Rpone.0192638.ref016)>>
endobj
26 0 obj
<>/Border[0 0 0]/Dest(Rpone.0192638.ref017)>>
endobj
27 0 obj
<>/Border[0 0 0]/Dest(Rpone.0192638.ref018)>>
endobj
28 0 obj
<>/Border[0 0 0]/Dest(Rpone.0192638.ref019)>>
endobj
29 0 obj
<>/Border[0 0 0]/A 30 0 R>>
endobj
30 0 obj
<>
endobj
11 0 obj
[31 0 R 32 0 R 33 0 R 34 0 R 35 0 R 36 0 R 37 0 R 38 0 R 39 0 R 40 0 R 41 0 R 42 0 R 43 0 R 44 0 R 45 0 R 46 0 R 47 0 R 48 0 R 49 0 R]
endobj
31 0 obj
<>stream
q
0.45 0.36 0.35 0.01 k
0 w
575.9997 647.9101 m
199.9998 647.9101 l
199.9998 648.4102 l
575.9997 648.4102 l
f*
0.83 0.64 0.02 0 k
564.3213 536.9386 m
569.0268 536.9386 l
h
f*
310.4504 497.9339 m
315.2126 497.9339 l
h
f*
317.4803 497.9339 m
322.2425 497.9339 l
h
f*
249.2787 458.9291 m
254.0409 458.9291 l
h
f*
259.2567 458.9291 m
264.0189 458.9291 l
h
f*
203.4142 432.9071 m
208.1764 432.9071 l
h
f*
210.3874 432.9071 m
215.1496 432.9071 l
h
f*
285.1654 380.9197 m
294.6898 380.9197 l
h
f*
296.9008 380.9197 m
306.4252 380.9197 l
h
f*
225.8079 354.8976 m
235.3323 354.8976 l
h
f*
203.4142 315.9496 m
212.9386 315.9496 l
h
f*
407.9622 289.9276 m
417.4866 289.9276 l
h
f*
419.6976 289.9276 m
429.222 289.9276 l
h
f*
381.2031 172.9134 m
390.7276 172.9134 l
h
f*
392.9953 172.9134 m
402.463 172.9134 l
h
f*
311.9244 146.948 m
321.3921 146.948 l
h
f*
479.2819 107.9433 m
488.8063 107.9433 l
h
f*
0 g
1 j
1 J
11.4998 0 0 11.4998 200.0125 706.3937 cm
BT
/F2 1 Tf
1 TL
-0.0035 Tc
0 0 Td
(Conclusions)Tj
ET
Q
q
1 j
1 J
0 w
9.5 0 0 9.5 200.0125 689.3858 cm
BT
/F0 1 Tf
1 TL
-0.0042 Tc
0 0 Td
(Seroconversion)Tj
7.0895 0 Td
(induced)Tj
3.6701 0 Td
(by)Tj
1.2652 0 Td
(a)Tj
0.7698 0 Td
(booster)Tj
3.5209 0 Td
(dose)Tj
2.3632 0 Td
(of)Tj
1.0444 0 Td
(vaccine)Tj
3.5686 0 Td
(correlates)Tj
4.5593 0 Td
(with)Tj
1.9813 0 Td
(the)Tj
1.5933 0 Td
(development)Tj
5.8782 0 Td
(of)Tj
1.0503 0 Td
(T)Tj
-38.3541 -1.474 Td
(cell)Tj
1.6948 0 Td
(immunological)Tj
6.5286 0 Td
(memory)Tj
3.8014 0 Td
(in)Tj
0.9846 0 Td
(HIV-infected)Tj
5.6693 0 Td
(patients)Tj
3.6821 0 Td
(who)Tj
2.029 0 Td
(did)Tj
1.5336 0 Td
(not)Tj
1.5994 0 Td
(respond)Tj
3.7894 0 Td
(to)Tj
1.0444 0 Td
(the)Tj
1.5933 0 Td
(standard)Tj
-33.9499 -1.468 Td
(immunization.)Tj
6.3197 0 Td
(Alternate)Tj
4.1774 0 Td
(immunization)Tj
6.0452 0 Td
(schedules)Tj
4.6667 0 Td
(need)Tj
2.4169 0 Td
(to)Tj
1.0443 0 Td
(be)Tj
1.3189 0 Td
(considered)Tj
5.0486 0 Td
(in)Tj
0.9847 0 Td
(NRs.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 593.9716 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Introduction)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 577.0204 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Chronic)Tj
3.5262 0 Td
(viral)Tj
1.9956 0 Td
(hepatitis)Tj
3.6113 0 Td
(has)Tj
1.5421 0 Td
(become)Tj
3.3278 0 Td
(a)Tj
0.652 0 Td
(major)Tj
2.6078 0 Td
(source)Tj
2.8347 0 Td
(of)Tj
1.0148 0 Td
(comorbidity)Tj
5.1703 0 Td
(in)Tj
1.0375 0 Td
(Human)Tj
3.3165 0 Td
(Immunodefi-)Tj
-30.6366 -1.3039 Td
(ciency)Tj
2.7609 0 Td
(Virus)Tj
2.4378 0 Td
(\(HIV\))Tj
2.7042 0 Td
(infected)Tj
3.4186 0 Td
(populations,)Tj
5.1817 0 Td
(with)Tj
1.9955 0 Td
(improved)Tj
4.1102 0 Td
(survival)Tj
3.3336 0 Td
(due)Tj
1.7007 0 Td
(to)Tj
1.0262 0 Td
(the)Tj
1.4683 0 Td
(success)Tj
3.1011 0 Td
(of)Tj
1.0148 0 Td
(antire-)Tj
-34.2536 -1.2982 Td
(troviral)Tj
3.1691 0 Td
(therapy)Tj
3.2484 0 Td
(\(ART\).)Tj
3.0388 0 Td
(A)Tj
0.907 0 Td
(high)Tj
2.007 0 Td
(incidence)Tj
4.0705 0 Td
(of)Tj
1.0148 0 Td
(both)Tj
2.0636 0 Td
(acute)Tj
2.3244 0 Td
(and)Tj
1.7291 0 Td
(chronic)Tj
3.2939 0 Td
(HBV)Tj
2.262 0 Td
(infection)Tj
3.787 0 Td
(is)Tj
0.8504 0 Td
(seen)Tj
1.9786 0 Td
(in)Tj
-35.7446 -1.2983 Td
(HIV-infected)Tj
5.5728 0 Td
(patients,)Tj
3.5943 0 Td
(probably)Tj
3.7644 0 Td
(because)Tj
3.3165 0 Td
(both)Tj
2.0636 0 Td
(viruses)Tj
2.9821 0 Td
(share)Tj
2.3414 0 Td
(the)Tj
1.4683 0 Td
(same)Tj
2.2564 0 Td
(route)Tj
2.347 0 Td
(of)Tj
1.0148 0 Td
(transmission)Tj
5.3688 0 Td
([)Tj
0.83 0.64 0.02 0 k
(1)Tj
0 g
(].)Tj
-36.0904 -1.3039 Td
(Notably,)Tj
3.6283 0 Td
(HIV)Tj
2.0239 0 Td
(complicates)Tj
4.9379 0 Td
(the)Tj
1.4684 0 Td
(natural)Tj
3.084 0 Td
(course)Tj
2.829 0 Td
(of)Tj
1.0148 0 Td
(HBV,)Tj
2.4888 0 Td
(resulting)Tj
3.7304 0 Td
(in)Tj
1.0374 0 Td
(greater)Tj
3.0047 0 Td
(levels)Tj
2.3755 0 Td
(of)Tj
1.0148 0 Td
(HBV)Tj
2.262 0 Td
(vire-)Tj
-34.8999 -1.2983 Td
(mia,)Tj
1.9672 0 Td
(higher)Tj
2.8006 0 Td
(rate)Tj
1.7461 0 Td
(of)Tj
1.0148 0 Td
(HBV)Tj
2.2621 0 Td
(reactivation,)Tj
5.176 0 Td
(chronic)Tj
3.2882 0 Td
(hepatitis)Tj
3.6113 0 Td
(and)Tj
1.7291 0 Td
(increased)Tj
4.0025 0 Td
(incidence)Tj
4.0705 0 Td
(of)Tj
1.0148 0 Td
(cirrhosis)Tj
-32.6832 -1.2982 Td
(and)Tj
1.7291 0 Td
(liver-related)Tj
5.0569 0 Td
(mortality)Tj
3.9175 0 Td
([)Tj
0.83 0.64 0.02 0 k
(2)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(3)Tj
0 g
(].)Tj
-9.5073 -1.304 Td
(Immune)Tj
3.702 0 Td
(responses)Tj
4.0932 0 Td
(to)Tj
1.0261 0 Td
(vaccination,)Tj
5.0513 0 Td
(seroconversion)Tj
6.2929 0 Td
(rates)Tj
2.109 0 Td
(and)Tj
1.7291 0 Td
(antibodies)Tj
4.3653 0 Td
(titers)Tj
2.2394 0 Td
(induced)Tj
3.4639 0 Td
(by)Tj
-35.2684 -1.2982 Td
(vaccination)Tj
4.8245 0 Td
(are)Tj
1.4513 0 Td
(known)Tj
3.0047 0 Td
(to)Tj
1.0205 0 Td
(be)Tj
1.1508 0 Td
(sub-optimal)Tj
5.057 0 Td
(in)Tj
1.0375 0 Td
(HIV-infected)Tj
5.5729 0 Td
(people,)Tj
3.0784 0 Td
(compared)Tj
4.2463 0 Td
(with)Tj
1.9955 0 Td
(the)Tj
1.4684 0 Td
(healthy)Tj
-33.9078 -1.2983 Td
(population)Tj
4.5864 0 Td
([)Tj
0.83 0.64 0.02 0 k
(4)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(7)Tj
0 g
(].)Tj
2.5965 0 Td
(Evaluation)Tj
4.5071 0 Td
(of)Tj
1.0148 0 Td
(HBV)Tj
2.262 0 Td
(vaccine)Tj
3.1974 0 Td
(efficacy)Tj
3.2202 0 Td
(is)Tj
0.8504 0 Td
(based)Tj
2.4718 0 Td
(on)Tj
1.2755 0 Td
(HBs)Tj
1.9276 0 Td
(antibody)Tj
3.7644 0 Td
(titers)Tj
2.2393 0 Td
(in)Tj
-33.9134 -1.2983 Td
(serum;)Tj
2.948 0 Td
(titers)Tj
2.2393 0 Td
(above)Tj
2.5455 0 Td
(10)Tj
1.1736 0 Td
(IU/ml)Tj
2.6872 0 Td
(are)Tj
1.4513 0 Td
(considered)Tj
4.6034 0 Td
(protective)Tj
4.201 0 Td
(as)Tj
1.0148 0 Td
(they)Tj
1.9275 0 Td
(are)Tj
1.4457 0 Td
(associated)Tj
4.2576 0 Td
(with)Tj
1.9956 0 Td
(protection)Tj
-32.4905 -1.3039 Td
([)Tj
0.83 0.64 0.02 0 k
(8)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(9)Tj
0 g
(].)Tj
2.3017 0 Td
(Nevertheless,)Tj
5.4935 0 Td
(it)Tj
0.788 0 Td
(is)Tj
0.8447 0 Td
(estimated)Tj
4.0762 0 Td
(that)Tj
1.7802 0 Td
(between)Tj
3.5262 0 Td
(4%)Tj
1.4514 0 Td
(and)Tj
1.7291 0 Td
(up)Tj
1.2699 0 Td
(to)Tj
1.0205 0 Td
(10%)Tj
1.9332 0 Td
(of)Tj
1.0148 0 Td
(healthy)Tj
3.1294 0 Td
(individuals)Tj
4.6488 0 Td
(vacci-)Tj
-35.0076 -1.2982 Td
(nated)Tj
2.4491 0 Td
(for)Tj
1.3889 0 Td
(HBV)Tj
2.2621 0 Td
(fail)Tj
1.4513 0 Td
(to)Tj
1.0261 0 Td
(achieve)Tj
3.1748 0 Td
(protection)Tj
4.3824 0 Td
(\(anti-HBs)Tj
4.1669 0 Td
(below)Tj
2.5908 0 Td
(10)Tj
1.1679 0 Td
(IU/ml\))Tj
3.033 0 Td
(as)Tj
1.0148 0 Td
(they)Tj
1.9219 0 Td
(are)Tj
1.4513 0 Td
(considered)Tj
-31.4813 -1.2983 Td
(non-responders.)Tj
6.8087 0 Td
(In)Tj
1.1112 0 Td
(addition,)Tj
3.8211 0 Td
(between)Tj
3.5319 0 Td
(13)Tj
1.1679 0 Td
(to)Tj
1.0261 0 Td
(60%)Tj
1.9276 0 Td
(of)Tj
1.0148 0 Td
(vaccinated)Tj
4.456 0 Td
(healthy)Tj
3.1351 0 Td
(individuals)Tj
4.6488 0 Td
(eventually)Tj
-32.6492 -1.3039 Td
(lose)Tj
1.7574 0 Td
(their)Tj
2.109 0 Td
(protection)Tj
4.3823 0 Td
(as)Tj
1.0148 0 Td
(anti-HBs)Tj
3.8268 0 Td
(titers)Tj
2.2393 0 Td
(tend)Tj
2.0183 0 Td
(to)Tj
1.0204 0 Td
(decrease)Tj
3.6114 0 Td
(over)Tj
1.9785 0 Td
(time,)Tj
2.2507 0 Td
(a)Tj
0.652 0 Td
(phenomenon)Tj
5.5955 0 Td
(known)Tj
3.0047 0 Td
(as)Tj
-35.4611 -1.2983 Td
(waning)Tj
3.5602 0 Td
(immunity)Tj
4.6148 0 Td
([)Tj
0.83 0.64 0.02 0 k
(10)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(11)Tj
0 g
(].)Tj
3.2542 0 Td
(The)Tj
1.7801 0 Td
(clinical)Tj
3.0784 0 Td
(importance)Tj
4.8302 0 Td
(of)Tj
1.0148 0 Td
(this)Tj
1.6725 0 Td
(phenomenon)Tj
5.5898 0 Td
(is)Tj
0.8504 0 Td
(however)Tj
3.6113 0 Td
(unclear)Tj
-33.8567 -1.2982 Td
(as)Tj
1.0147 0 Td
(it)Tj
0.7824 0 Td
(has)Tj
1.542 0 Td
(been)Tj
2.126 0 Td
(suggested)Tj
4.0705 0 Td
(that)Tj
1.7802 0 Td
(protection)Tj
4.3823 0 Td
(may)Tj
1.9276 0 Td
(still)Tj
1.6384 0 Td
(be)Tj
1.1508 0 Td
(maintained)Tj
4.7906 0 Td
(despite)Tj
3.0387 0 Td
(declining)Tj
3.9344 0 Td
(anti-HBs)Tj
3.8268 0 Td
(Ab)Tj
-36.0054 -1.304 Td
(titers)Tj
2.2393 0 Td
([)Tj
0.83 0.64 0.02 0 k
(12)Tj
0 g
(].)Tj
-1.0431 -1.2982 Td
(In)Tj
1.1111 0 Td
(the)Tj
1.4684 0 Td
(settings)Tj
3.2428 0 Td
(of)Tj
1.0148 0 Td
(HIV)Tj
2.0239 0 Td
(infection,)Tj
4.0195 0 Td
(it)Tj
0.7824 0 Td
(has)Tj
1.542 0 Td
(been)Tj
2.126 0 Td
(shown)Tj
2.8459 0 Td
(that)Tj
1.7802 0 Td
(CD4)Tj
2.0919 0 Td
(counts)Tj
2.8857 0 Td
(and)Tj
1.7291 0 Td
(viral)Tj
1.9956 0 Td
(load)Tj
1.9332 0 Td
(at)Tj
0.9524 0 Td
(the)Tj
-34.7411 -1.2983 Td
(time)Tj
2.0295 0 Td
(of)Tj
1.0148 0 Td
(vaccination)Tj
4.8246 0 Td
(are)Tj
1.4456 0 Td
(the)Tj
1.474 0 Td
(main)Tj
2.2848 0 Td
(factors)Tj
2.9083 0 Td
(affecting)Tj
3.651 0 Td
(the)Tj
1.474 0 Td
(possibility)Tj
4.2689 0 Td
(of)Tj
1.0148 0 Td
(observing)Tj
4.1273 0 Td
(seroconversion)Tj
-30.5176 -1.2983 Td
([)Tj
0.83 0.64 0.02 0 k
(13)Tj
0 g
(].)Tj
2.0749 0 Td
(However,)Tj
4.0762 0 Td
(response)Tj
3.736 0 Td
(rates)Tj
2.109 0 Td
(to)Tj
1.0205 0 Td
(vaccination)Tj
4.8302 0 Td
(differs)Tj
2.7439 0 Td
(widely)Tj
2.8233 0 Td
(between)Tj
3.5319 0 Td
(studies,)Tj
3.2088 0 Td
(possibly)Tj
3.4413 0 Td
(because)Tj
-33.596 -1.3039 Td
(of)Tj
1.0147 0 Td
(wide)Tj
2.1203 0 Td
(differences)Tj
4.5638 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(immune-virologica)Tj
7.7045 0 Td
(l)Tj
0.4649 0 Td
(status)Tj
2.5001 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4684 0 Td
(patients)Tj
3.3675 0 Td
(analyzed,)Tj
3.9288 0 Td
(the)Tj
1.4684 0 Td
(vaccine)Tj
-32.122 -1.2982 Td
(administration)Tj
6.1681 0 Td
(route)Tj
2.3471 0 Td
(and)Tj
1.7291 0 Td
(the)Tj
1.474 0 Td
(dosing)Tj
2.897 0 Td
(of)Tj
1.0148 0 Td
(vaccination)Tj
4.8245 0 Td
([)Tj
0.83 0.64 0.02 0 k
(14)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(15)Tj
0 g
(].)Tj
3.2542 0 Td
(Limited)Tj
3.3618 0 Td
(data)Tj
1.9106 0 Td
(suggest)Tj
3.1237 0 Td
(that)Tj
1.7802 0 Td
(it)Tj
0.7823 0 Td
(is)Tj
0.8504 0 Td
(pos-)Tj
-35.5178 -1.2983 Td
(sible)Tj
2.0239 0 Td
(to)Tj
1.0261 0 Td
(increase)Tj
3.4696 0 Td
(HBV-vaccine)Tj
5.5899 0 Td
(response)Tj
3.7304 0 Td
(rate)Tj
1.7461 0 Td
(in)Tj
1.0375 0 Td
(healthy)Tj
3.1351 0 Td
(and)Tj
1.7291 0 Td
(HIV-infected)Tj
5.5729 0 Td
(individuals)Tj
4.6487 0 Td
(by)Tj
1.1792 0 Td
(modi-)Tj
-34.8885 -1.3039 Td
(fying)Tj
2.245 0 Td
(vaccine)Tj
3.1918 0 Td
(dosing)Tj
2.897 0 Td
(regimens,)Tj
4.1272 0 Td
(such)Tj
2.0579 0 Td
(as)Tj
1.0148 0 Td
(doubling)Tj
3.8154 0 Td
(the)Tj
1.4684 0 Td
(standard)Tj
3.7247 0 Td
(antigen)Tj
3.2031 0 Td
(dose.)Tj
-26.5491 -1.2983 Td
(The)Tj
1.7858 0 Td
(production)Tj
4.7168 0 Td
(of)Tj
1.0148 0 Td
(HBV-specific)Tj
5.5785 0 Td
(antibodies)Tj
4.3654 0 Td
(by)Tj
1.1792 0 Td
(B)Tj
0.7993 0 Td
(lymphocytes)Tj
5.2554 0 Td
(needs)Tj
2.5059 0 Td
(the)Tj
1.4683 0 Td
(activation)Tj
4.1499 0 Td
(of)Tj
1.0148 0 Td
(those)Tj
-35.0303 -1.2983 Td
(CD4+)Tj
2.6758 0 Td
(T)Tj
0.8277 0 Td
(helper)Tj
2.7326 0 Td
(lymphocytes)Tj
5.2498 0 Td
(that)Tj
1.7801 0 Td
(will)Tj
1.6668 0 Td
(elicit)Tj
2.1429 0 Td
(B)Tj
0.7994 0 Td
(cell)Tj
1.5591 0 Td
(proliferation)Tj
5.2667 0 Td
(and)Tj
1.7291 0 Td
(their)Tj
2.109 0 Td
(differentiation)Tj
5.981 0 Td
(into)Tj
-34.52 -1.3039 Td
(Ab-secreting)Tj
5.3404 0 Td
(plasmacells.)Tj
4.9606 0 Td
(The)Tj
1.7801 0 Td
(adjuvants)Tj
4.0649 0 Td
(included)Tj
3.7134 0 Td
(in)Tj
1.0318 0 Td
(HBV)Tj
2.262 0 Td
(vaccines,)Tj
3.7814 0 Td
(such)Tj
2.0636 0 Td
(as)Tj
1.0148 0 Td
(alum,)Tj
2.4718 0 Td
(stimulate)Tj
-32.4848 -1.2982 Td
(the)Tj
1.4683 0 Td
(migration)Tj
4.2009 0 Td
(of)Tj
1.0148 0 Td
(dendritic)Tj
3.8721 0 Td
(cells)Tj
1.9219 0 Td
(\(DCs\))Tj
2.6589 0 Td
(towards)Tj
3.4015 0 Td
(the)Tj
1.474 0 Td
(site)Tj
1.5704 0 Td
(of)Tj
1.0148 0 Td
(injection)Tj
3.7587 0 Td
(and,)Tj
1.9559 0 Td
(after)Tj
2.0353 0 Td
(antigen)Tj
3.2031 0 Td
(capture,)Tj
-33.5506 -1.2983 Td
(their)Tj
2.1089 0 Td
(homing)Tj
3.3505 0 Td
(into)Tj
1.8426 0 Td
(the)Tj
1.4683 0 Td
(lymph)Tj
2.7893 0 Td
(nodes,)Tj
2.8119 0 Td
(where)Tj
2.6476 0 Td
(antigens)Tj
3.5659 0 Td
(will)Tj
1.6668 0 Td
(be)Tj
1.1508 0 Td
(processed)Tj
4.1329 0 Td
(and)Tj
1.7348 0 Td
(presented)Tj
4.1102 0 Td
(to)Tj
1.0262 0 Td
(CD4)Tj
-34.4067 -1.3039 Td
(+)Tj
0.7993 0 Td
(T)Tj
0.8277 0 Td
(cells.)Tj
2.1487 0 Td
(These)Tj
2.5681 0 Td
(CD4+)Tj
2.6759 0 Td
(T)Tj
0.8277 0 Td
(cells)Tj
1.9219 0 Td
(will)Tj
1.6611 0 Td
(trigger)Tj
2.8857 0 Td
(antibody)Tj
3.7644 0 Td
(production)Tj
4.7168 0 Td
(by)Tj
1.1792 0 Td
(secreting)Tj
3.804 0 Td
(cytokines,)Tj
4.2236 0 Td
(thus)Tj
-34.0041 -1.2983 Td
(establishing)Tj
4.9265 0 Td
(a)Tj
0.652 0 Td
(long-lasting)Tj
4.9606 0 Td
(immune)Tj
3.6227 0 Td
(memory)Tj
3.6169 0 Td
([)Tj
0.83 0.64 0.02 0 k
(16)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(17)Tj
0 g
(].)Tj
3.2542 0 Td
(Notably,)Tj
3.6283 0 Td
(it)Tj
0.788 0 Td
(is)Tj
0.8448 0 Td
(conceivable)Tj
4.8812 0 Td
(that)Tj
1.7745 0 Td
(a)Tj
0.6576 0 Td
(fully)Tj
-33.6073 -1.2982 Td
(effective)Tj
3.5092 0 Td
(vaccine)Tj
3.1918 0 Td
(would)Tj
2.7156 0 Td
(elicit)Tj
2.143 0 Td
(CTL-mediated)Tj
6.1058 0 Td
(effector)Tj
3.2428 0 Td
(mechanisms)Tj
5.21 0 Td
(as)Tj
1.0148 0 Td
(well,)Tj
2.0409 0 Td
(as)Tj
1.0148 0 Td
(these)Tj
2.2564 0 Td
(are)Tj
1.4457 0 Td
(essential)Tj
-33.8908 -1.2983 Td
(in)Tj
1.0318 0 Td
(clearing)Tj
3.4015 0 Td
(HBV)Tj
2.262 0 Td
(infections)Tj
4.1556 0 Td
([)Tj
0.83 0.64 0.02 0 k
(18)Tj
0 g
(].)Tj
-9.6547 -1.3039 Td
(Current)Tj
3.4242 0 Td
(guidelines)Tj
4.2803 0 Td
(recommend)Tj
5.0853 0 Td
(a)Tj
0.652 0 Td
(booster)Tj
3.1974 0 Td
(dose)Tj
2.0353 0 Td
(of)Tj
1.0148 0 Td
(HBV)Tj
2.262 0 Td
(vaccine)Tj
3.1975 0 Td
(in)Tj
1.0375 0 Td
(HIV-infected)Tj
5.5728 0 Td
(patients)Tj
3.3676 0 Td
(in)Tj
-36.3229 -1.2983 Td
(whom)Tj
2.7552 0 Td
(seroconversion)Tj
6.2986 0 Td
(is)Tj
0.8447 0 Td
(not)Tj
1.576 0 Td
(achieved)Tj
3.702 0 Td
(but)Tj
1.5534 0 Td
(there)Tj
2.2621 0 Td
(is)Tj
0.8503 0 Td
(still)Tj
1.6385 0 Td
(controversy)Tj
4.9379 0 Td
(about)Tj
2.4945 0 Td
(the)Tj
1.4683 0 Td
(risk)Tj
1.7178 0 Td
(of)Tj
1.0148 0 Td
(viral)Tj
1.9956 0 Td
(load)Tj
-35.1097 -1.2983 Td
(rebound)Tj
3.6339 0 Td
(in)Tj
1.0318 0 Td
(HIV-infected)Tj
5.5729 0 Td
(patients,)Tj
3.5943 0 Td
(especially)Tj
4.0195 0 Td
(in)Tj
1.0318 0 Td
(pediatric)Tj
3.7531 0 Td
(populations)Tj
4.9492 0 Td
([)Tj
0.83 0.64 0.02 0 k
(19)Tj
0 g
(].)Tj
-26.3903 -1.3039 Td
(We)Tj
1.61 0 Td
(analyzed)Tj
3.7021 0 Td
(the)Tj
1.4683 0 Td
(immunological)Tj
6.3042 0 Td
(effects)Tj
2.7212 0 Td
(of)Tj
1.0148 0 Td
(a)Tj
0.6577 0 Td
(booster)Tj
3.1918 0 Td
(dose)Tj
2.0409 0 Td
(of)Tj
1.0148 0 Td
(HBV)Tj
2.262 0 Td
(vaccine)Tj
3.1918 0 Td
(on)Tj
1.2756 0 Td
(HBV-specific)Tj
-31.6514 -1.2982 Td
(humoral)Tj
3.651 0 Td
(and)Tj
1.7291 0 Td
(cell-mediate)Tj
5.108 0 Td
(immune)Tj
3.6226 0 Td
(responses)Tj
4.0932 0 Td
(in)Tj
1.0375 0 Td
(HIV-infected)Tj
5.5729 0 Td
(young)Tj
2.7269 0 Td
(patients.)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 440.1637 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(HBV)Tj
2.2464 0 Td
(vaccine)Tj
3.5504 0 Td
(in)Tj
0.978 0 Td
(HIV-infected)Tj
5.6339 0 Td
(individuals)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
0.83 0.64 0.02 0 k
81.5811 34.9228 m
237.8835 34.9228 l
h
f*
0 g
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.83 0.64 0.02 0 k
0.4748 0 Td
(https://doi.or)Tj
5.4142 0 Td
(g/10.137)Tj
3.8198 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.01926)Tj
4.089 0 Td
(38)Tj
0 g
2.0906 0 Td
(February)Tj
4.1599 0 Td
(14,)Tj
1.5874 0 Td
(2018)Tj
33.1585 0 Td
(2)Tj
0.7654 0 Td
(/)Tj
ET
endstream
endobj
32 0 obj
<>stream
endstream
endobj
33 0 obj
<>stream
endstream
endobj
34 0 obj
<>stream
endstream
endobj
35 0 obj
<>stream
endstream
endobj
36 0 obj
<>stream
endstream
endobj
37 0 obj
<>stream
endstream
endobj
38 0 obj
<>stream
endstream
endobj
39 0 obj
<>stream
endstream
endobj
40 0 obj
<>stream
endstream
endobj
41 0 obj
<>stream
endstream
endobj
42 0 obj
<>stream
endstream
endobj
43 0 obj
<>stream
endstream
endobj
44 0 obj
<>stream
endstream
endobj
45 0 obj
<>stream
endstream
endobj
46 0 obj
<>stream
endstream
endobj
47 0 obj
<>stream
endstream
endobj
48 0 obj
<>stream
endstream
endobj
49 0 obj
<>stream
BT
66.402 0 Td
(11)Tj
ET
Q
endstream
endobj
50 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 9 0 R/Annots 56 0 R/Contents 57 0 R/TrimBox[0 0 612 792]>>
endobj
52 0 obj
<>
endobj
58 0 obj
<>
endobj
59 0 obj
<>stream
%!PS-AdobeFont-1.0
11 dict begin
/FontName /PI_chars_3 def
/FontType 1 def
/FontBBox {-11 -345 1373 718} readonly def
/FontMatrix [0.001 0 0 0.001 0 0] readonly def
/PaintType 0 def
/FontInfo 8 dict dup begin
/FullName (PI_chars_3) readonly def
/BaseFontName (PI_chars_3) def
end def
/Encoding 256 array
0 1 255 {1 index exch /.notdef put} for
dup 33 /exclam put
dup 34 /quotedbl put
dup 35 /numbersign put
dup 36 /dollar put
dup 37 /percent put
dup 38 /ampersand put
dup 39 /quoteright put
dup 40 /parenleft put
dup 41 /parenright put
dup 42 /asterisk put
dup 43 /plus put
dup 44 /comma put
dup 45 /hyphen put
dup 46 /period put
dup 47 /slash put
dup 49 /one put
dup 50 /two put
dup 51 /three put
dup 52 /four put
dup 53 /five put
dup 54 /six put
dup 55 /seven put
dup 56 /eight put
dup 58 /colon put
dup 60 /less put
dup 61 /equal put
dup 62 /greater put
dup 63 /question put
dup 64 /at put
dup 65 /A put
dup 66 /B put
dup 67 /C put
dup 68 /D put
dup 69 /E put
dup 70 /F put
dup 71 /G put
dup 72 /H put
dup 73 /I put
dup 74 /J put
dup 75 /K put
dup 76 /L put
dup 77 /M put
dup 78 /N put
dup 79 /O put
dup 80 /P put
dup 81 /Q put
dup 82 /R put
dup 83 /S put
dup 84 /T put
dup 85 /U put
dup 86 /V put
dup 87 /W put
dup 88 /X put
dup 89 /Y put
dup 90 /Z put
dup 91 /bracketleft put
dup 92 /backslash put
dup 93 /bracketright put
dup 94 /asciicircum put
dup 97 /a put
dup 98 /b put
dup 99 /c put
dup 100 /d put
dup 101 /e put
dup 102 /f put
dup 103 /g put
dup 104 /h put
dup 105 /i put
dup 106 /j put
dup 107 /k put
dup 108 /l put
dup 109 /m put
dup 110 /n put
dup 111 /o put
dup 112 /p put
dup 113 /q put
dup 114 /r put
dup 115 /s put
dup 116 /t put
dup 117 /u put
dup 118 /v put
dup 119 /w put
dup 120 /x put
dup 121 /y put
dup 122 /z put
dup 123 /braceleft put
dup 124 /bar put
dup 125 /braceright put
dup 126 /asciitilde put
readonly def
currentdict end
currentfile eexec
M#1H5 J6o\&rtS(#v\0\V7Fe༙OYx5-cY9^%Y6
(efIOldN"wȰ;)UƽoFg/rvV$JS8_oc@
o9-eGJp}[Do]mN=4*{ܯq=eU^t6¤/{zM4aܪ
Q:д'B-r^ܦ6y?rRnu S\U{Oλrs(Βƚ
#d29%s'ƈT1F8&\0Xd&&Zug'VPd]:>u=Q,?#(CV4'..|ӱ5 h
sȀg)fɘ`UXK^>] q\l#5pE"JO}rquáQBr/E7
QW5\GSlu{7ZH(PSf/O;̟w{ɴ}-K hA8!b!U>`#u?Vlnǝ19V+mg'QmA}S Y$í8n uJ ڒx3>[x0Z]
ͩw4M&1+pkC,sr"%q&OjbH{:5$65*S`cr;%s4Oӆe>T+6~pBOD!$c]"~r#nh6$38i˞[~Z}}rHmte9(1½=j{<\ ;? RA?c{Rf1'VԞ_-Lwo]`.l|zjf"![G1BYro˓9[-+z g!}RN+pX!M~HcFh@g%J6B)6!Lq>TX\ݪGF
PiQݓX~Fs;Ölo4/(C?+,ɖxۼ:xU^)
fd,`*>-:}=q$:\Xzcw1Nf(
ZkEeJXfэi@zXc\{a5qKg\5ݩv\Qe%1>OY̗$Y#P[)."^+{"bP]Bt&zeN6
іijDE% 0;̅
~~lfB>u'i4znym%tfԟ^נBTDS6-ghiWk/(r!!˶fc>趕%U